Drugs

FDA Drug Safety Podcasts by Date

CDER Drug Safety Podcasts

The FDA Drug Safety Podcasts are produced by FDA's Center for Drug Evaluation and Research (CDER). They provide emerging safety information about drugs in conjunction with the release of Public Health Advisories and other drug safety issues.

All Drug Safety Podcast:

Title Date Link to Podcast Link to Transcript
FDA warns about rare but serious allergic reactions with the skin antiseptic chlorhexidine gluconate February 2, 2017 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA revises description of mental health side effects of stop-smoking medicines Chantix and Zyban to reflect clinical trial findings December 16, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women December 14, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
Updated FDA review concludes that use of pioglitazone may be linked to an increased risk of bladder cancer December 12, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about the risk of hepatitis B reactivating in some patients treated with direct-acting antivirals for hepatitis C October 4, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning August 31, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects July 26, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA strengthens kidney warnings for diabetes medicines canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR) June 14, 2016 Listen to This Podcast
Run Time:
00:3:04
Transcript
Update: FDA evaluating the risk of burns and scars with Zecuity (sumatriptan) migraine patch June 10, 2016   Listen to This Podcast
Run Time:
00:1:12
 Transcript
FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse
 
June 7, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about serious bleeding risk with over-the-counter antacid products containing aspirin June 6, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA evaluating the risk of burns and scars with Zecuity (sumatriptan) migraine patch June 2, 2016 Listen to This Podcast
Run Time:
00:1:58
Transcript
FDA warns that prescribing of Nizoral (ketoconazole) oral tablets for unapproved uses including skin and nail infections continues; linked to patient death May 19, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
Interim clinical trial results find increased risk of leg and foot amputations, mostly affecting the toes, with the diabetes medicine canagliflozin (Invokana, Invokamet); FDA to investigate May 18, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together May 12, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about rare but serious skin reactions with mental health drug olanzapine (Zyprexa, Zyprexa Zydis, Zyprexa Relprevv, and Symbyax) May 10, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about new impulse-control problems associated with mental health drug aripiprazole (Abilify, Abilify Maintena, Aristada) May 3, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA approves brand name change for antidepressant drug Brintellix (vortioxetine) to avoid confusion with antiplatelet drug Brilinta (ticagrelor) May 2, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA to review study examining use of oral fluconazole (Diflucan) in pregnancy April 26, 2016 Listen to This Podcast
Run Time:
00:2:00
Transcript
FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function April 8, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA announced that a safety review has found type 2 diabetes medicines containing saxagliptin and alogliptin may increase the risk of heart failure April 5, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about several safety issues with opioid pain medicines; requires label changes March 29, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved January 4, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA eliminates the Risk Evaluation and Mitigation Strategy (REMS) for rosiglitazone-containing diabetes medicines December 16, 2015 Listen to This Podcast
Run Time:
00:2:00
Transcript
FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections December 4, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA advises of rare cases of underactive thyroid in infants given iodine-containing contrast agents for medical imaging November 17, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA review finds long-term treatment with blood-thinning medicine Plavix (clopidogrel) does not change risk of death November 6, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA review found no increased cardiovascular risks with Parkinson’s disease drug entacapone October 26, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns of serious liver injury risk with hepatitis C treatments Viekira Pak and Technivie October 22, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA requires drug interaction studies with potassium-lowering drug Kayexalate (sodium polystyrene sulfonate) October 22, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA cautions about dose confusion and medication error with antibacterial drug Avycaz (ceftazidime and avibactam) September 22, 2015 Listen to This Podcast
Run Time:
00:2:00
Transcript
FDA evaluating the risks of using the pain medicine tramadol in children aged 17 and younger September 21, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA modifies monitoring for neutropenia associated with schizophrenia medicine clozapine; approves new shared REMS program for all clozapine medicines September 15, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA revises label of diabetes drug canagliflozin (Invokana, Invokamet) to include updates on bone fracture risk and new information on decreased bone mineral density September 10, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns that DPP-4 inhibitors for type 2 diabetes may cause severe joint pain August 28, 2015 Listen to This Podcast
Run Time:
00:2:00
Transcript
FDA warns of severe adverse events with application of Picato (ingenol mebutate) gel for skin condition; requires label changes August 21, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs August 4, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor) July 30, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA evaluating the risk of brain deposits with repeated use of gadolinium-based contrast agents for magnetic resonance imaging (MRI) July 27, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about a serious lung condition in infants and newborns treated with Proglycem (diazoxide) July 16, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes July 9, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA evaluating the potential risks of using codeine cough-and-cold medicines in children July 1, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA reporting permanent skin color changes associated with use of Daytrana patch (methylphenidate transdermal system) for treating ADHD June 24, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA determines 2013 labeling adequate to manage risk of retinal abnormalities, potential vision loss, and skin discoloration with anti-seizure drug Potiga (ezogabine); requires additional study June 16, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam) May 20, 2015 Listen to This Podcast
Run Time:
00:2:00
Transcript
FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood May 15, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol) March 30, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns of serious slowing of the heart rate when antiarrhythmic drug amiodarone is used with hepatitis C treatments containing sofosbuvir Harvoni or Sovaldi in combination with another Direct Acting Antiviral drug March 24, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA review of study sheds light on two deaths associated with the injectable schizophrenia drug Zyprexa Relprevv (olanzapine pamoate) March 23, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA updates label for stop smoking drug Chantix (varenicline) to include potential alcohol interaction, rare risk of seizures, and studies of side effects on mood, behavior, or thinking March 9, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use March 3, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients February 25, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA has reviewed possible risks of pain medicine use during pregnancy January 9, 2015 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA reporting mental health drug ziprasidone (Geodon) associated with rare but potentially fatal skin reactions December 11, 2014 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about case of rare brain infection PML with MS drug Tecfidera (dimethyl fumarate) November 25, 2014 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA reviews long-term antiplatelet therapy as preliminary trial data shows benefits but a higher risk of non-cardiovascular death November 16, 2014 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA approves label changes for asthma drug Xolair (omalizumab), including describing slightly higher risk of heart and brain adverse events September 26, 2014 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA recommends not using lidocaine to treat teething pain and requires new Boxed Warning June 26, 2014 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns of rare but serious hypersensitivity reactions with certain over-the-counter topical acne products June 25, 2014 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA review of cardiovascular risks for diabetics taking hypertension drug olmesartan not conclusive; label updates required June 24, 2014 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns that cancer drug docetaxel may cause symptoms of alcohol intoxication after treatment June 20, 2014 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA adding general warning to testosterone products about potential for venous blood clots June 19, 2014 Listen to This Podcast
Run Time:
00:2:00
Transcript
FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose May 15, 2014 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA study of Medicare patients finds risks lower for stroke and death but higher for gastrointestinal bleeding with Pradaxa (dabigatran) compared to warfarin May 13, 2014 Listen to This Podcast
Run Time:
00:3:00

 
Transcript
FDA requires label changes to warn of rare but serious neurologic problems after epidural corticosteroid injections for pain April 23, 2014 Listen to This Podcast
Run Time:
00:3:00

 
Transcript
FDA clarifies Warning about Pediatric Use of Revatio (sildenafil) for Pulmonary Arterial Hypertension March 31, 2014 Listen to This Podcast
Run Time:
00:1:58
Transcript
FDA approves label changes for antibacterial Doribax (doripenem) describing increased risk of death for ventilator patients with pneumonia March 6, 2014 Listen to This Podcast
Run Time:
00:2:00
Transcript
FDA to review heart failure risk with diabetes drug saxagliptin (marketed as Onglyza and Kombiglyze XR) February 11, 2014 Listen to This Podcast
Run Time:
00:1:59
Transcript
FDA evaluating risk of stroke, heart attack and death with FDA-approved testosterone products January 31, 2014 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns of possible harm from exceeding recommended dose of over-the-counter sodium phosphate products to treat constipation January 8, 2014 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA requires multiple new safety measures for leukemia drug Iclusig; company expected to resume marketing December 20, 2013 Listen to This Podcast
Run Time:
00:6:21
Transcript
FDA warns of rare risk of long-lasting erections in males taking methylphenidate ADHD medications and has approved label changes December 18, 2013 Listen to This Podcast
Run Time:
00:6:08
Transcript
FDA warns of serious skin reactions with the anti-seizure drug Onfi (clobazam) and has approved label changes  December 3, 2013 Listen to This Podcast
Run Time:
00:4:24
Transcript
FDA requires removal of some prescribing and dispensing restrictions for rosiglitazone-containing diabetes medicines   November 25, 2013 Listen to This Podcast
Run Time:
00:4:35
Transcript
FDA warns of rare but serious risk of heart attack and death with cardiac nuclear stress test drugs Lexiscan (regadenoson) and Adenoscan (adenosine) November 20, 2013  Listen to This Podcast
Run Time:
00:4:57
Transcript
FDA requests label changes and single-use packaging for some over-the-counter topical antiseptic products to decrease risk of infection November 13, 2013  Listen to This Podcast
Run Time:
00:6:01
Transcript
Updated recommendations to decrease risk of spinal column bleeding and paralysis in patients on low molecular weight heparins November 6, 2013 Listen to This Podcast
Run Time:
00:7:24
Transcript
FDA approves label changes for anti-seizure drug Potiga (ezogabine) describing risk of retinal abnormalities, potential vision loss, and skin discoloration October 31, 2013 Listen to This Podcast
Run Time:
00:3:14
Transcript
FDA asks manufacturer of the leukemia drug Iclusig (ponatinib) to suspend marketing and sales October 31, 2013 Listen to This Podcast
Run Time:
00:5:16
Transcript
FDA investigating leukemia drug Iclusig (ponatinib) after increased reports of serious blood clots in arteries and veins October 17, 2013 Listen to This Podcast
Run Time:
00:4:06
Transcript
FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning September 27, 2013 Listen to This Podcast
Run Time:
00:3:47
Transcript
Boxed Warning and new recommendations to decrease risk of hepatitis B reactivation with the immune-suppressing and anti-cancer drugs Arzerra (ofatumumab) and Rituxan (rituximab) September 25, 2013 Listen to This Podcast
Run Time:
00:7:29
Transcript
FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death September 23, 2013 Listen to This Podcast
Run Time:
00:4:41
Transcript
FDA investigating rare brain infection in patient taking Gilenya (fingolimod) August 29, 2013 Listen to This Podcast
Run Time:
00:3:39
Transcript
FDA requires label changes to warn of risk for possibly permanent nerve damage from antibacterial fluoroquinolone drugs taken by mouth or by injection
 
August 16, 2013 Listen to This Podcast
Run Time:
00:3:28
Transcript
FDA warns of rare but serious skin reactions with the pain reliever/fever reducer acetaminophen August 1, 2013 Listen to This Podcast
Run Time:
00:5:43
Transcript
FDA approves label changes for antimalarial drug mefloquine hydrochloride due to risk of serious psychiatric and nerve side effects July 29, 2013 Listen to This Podcast
Run Time:
00:3:48
Transcript
FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems July 26, 2013 Listen to This Podcast
Run Time:
00:7:35
Transcript
FDA approves label changes to include intestinal problems (sprue-like enteropathy) linked to blood pressure medicine olmesartan medoxomil July 3, 2013 Listen to This Podcast
Run Time:
00:2:50
Transcript
FDA is investigating two deaths following injection of long-acting antipsychotic Zyprexa Relprevv (olanzapine pamoate) June 18, 2013 Listen to This Podcast
Run Time:
00:3:08
Transcript
FDA Recommends Against Prolonged Use of Magnesium Sulfate to Stop Pre-term Labor Due to Bone Changes in Exposed Babies May 30, 2013 Listen to This Podcast
Run Time:
00:4:37
Transcript
FDA approves label changes for zolpidem products, including new dosing and a recommendation to avoid driving the day after Ambien CR use May 14, 2013 Listen to This Podcast
Run Time:
00:3:49
Transcript
FDA Drug Podcast: Valproate Anti-seizure Products Contraindicated for Migraine Prevention in Pregnant Women due to Decreased IQ Scores in Exposed Children May 6, 2013 Listen to This Podcast
Run Time:
00:8:43
Transcript
FDA warns about potential medication errors resulting from confusion regarding nonproprietary name for breast cancer drug Kadcyla (ado-trastuzumab emtansine) May 6, 2013 Listen to This Podcast
Run Time:
00:6:28
Transcript
FDA limits duration and usage of Samsca (tolvaptan) due to possible liver injury leading to organ transplant or death April 30, 2013 Listen to This Podcast
Run Time:
00:3:38
Transcript
Anti-seizure drug Potiga (ezogabine) linked to retinal abnormalities and blue skin discoloration April 26, 2013 Listen to This Podcast
Run Time:
00:4:39
Transcript
FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes March 14, 2013 Listen to This Podcast
Run Time:
00:4:29
Transcript
Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms March 12, 2013 Listen to This Podcast
Run Time:
00:5:21
Transcript
FDA suspends pediatric clinical trials of Sensipar (cinacalcet hydrochloride) after report of death February 27, 2013 Listen to This Podcast
Run Time:
00:3:47
Transcript
Safety review update of codeine use in children; new Boxed Warning and Contraindication on use after tonsillectomy and/or adenoidectomy February 21, 2013 Listen to This Podcast
Run Time:
00:5:25
Transcript
Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem January 11, 2013 Listen to This Podcast
Run Time:
00:6:15
Transcript
Serious skin reactions after combination treatment with the Hepatitis C drugs Incivek (telaprevir), peginterferon alfa, and ribavirin December 26, 2012 Listen to This Podcast
Run Time:
00:5:46
Transcript
Warning against use of Xyrem (sodium oxybate) with alcohol or drugs causing respiratory depression December 21, 2012 Listen to This Podcast
Run Time:
00:4:53
Transcript
Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves December 21, 2012 Listen to This Podcast
Run Time:
00:3:58
Transcript
Safety review update of Chantix (varenicline) and risk of cardiovascular adverse events December 13, 2012 Listen to This Podcast
Run Time:
00:4:19
Transcript
Important change to heparin container labels to clearly state the total drug strength December 7, 2012 Listen to This Podcast
Run Time:
00:3:56
Transcript
Updated information on 32 mg intravenous ondansetron (Zofran) dose and pre-mixed ondansetron products December 6, 2012 Listen to This Podcast
Run Time:
00:3:43
Transcript
Investigation into New England Compounding Center November 13, 2012 Listen to This Podcast
Run Time:
00:3:00
Transcript
Ameridose November 13, 2012 Listen to This Podcast
Run Time:
00:2:00
Transcript
Update on the risk for serious bleeding events with the anticoagulant Pradaxa November 2, 2012 Listen to This Podcast
Run Time:
00:5:30
Transcript
Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays October 25, 2012 Listen to This Podcast
Run Time:
00:4:01
Transcript
Ongoing safety review of Parkinson’s drug Mirapex (pramipexole) and possible risk of heart failure September 21, 2012 Listen to This Podcast
Run Time:
00:3:06
Transcript
Rare cases of serious burns with the use of over-the-counter topical muscle and joint pain relievers August 30, 2012 Listen to This Podcast
Run Time:
00:3:46
Transcript
FDA recommends against use of Revatio in children with pulmonary hypertension August 30, 2012 Listen to This Podcast
Run Time:
00:3:06
Transcript
Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death August 15, 2012 Listen to This Podcast
Run Time:
00:4:22
Transcript
Seizure risk for multiple sclerosis patients who take Ampyra (dalfampridine) July 23, 2012 Listen to This Podcast
Run Time:
00:4:29
Transcript
Cefepime and risk of seizure in patients not receiving dosage adjustments for kidney impairment June 26, 2012

Listen to This Podcast
Run Time:
00:3:17

Transcript
FDA advises healthcare providers to visually inspect Hospira Carpuject pre-filled cartridges for overfill May 23, 2012

Listen to This Podcast
Run Time:
00:3:14

Transcript
Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod) May 14, 2012

Listen to This Podcast
Run Time:
00:3:47

Transcript
Safety review update of cancer drug Revlimid (lenalidomide) and risk of developing new types of malignancies May 7, 2012

Listen to This Podcast
Run Time:
00:3:02

Transcript
Updated information on drug interactions between Victrelis (boceprevir) and certain boosted HIV protease inhibitor drugs April 26, 2012

Listen to This Podcast
Run Time:
00:3:55

Transcript
New Warning and Contraindication for blood pressure medicines containing aliskiren (Tekturna) April 20, 2012

Listen to This Podcast
Run Time:
00:3:45

Transcript
Updated information about the risk of blood clots in women taking birth control pills containing drospirenone April 11, 2012

Listen to This Podcast
Run Time:
00:05:29

Transcript
Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses March 30, 2012

Listen to This Podcast
Run Time:
00:05:29

Transcript
Interactions  between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs  can increase the risk of muscle injury March 2, 2012

Listen to This Podcast
Run Time:
00:03:37

Transcript
Important safety label changes to cholesterol-lowering statin drugs March 2, 2012

Listen to This Podcast
Run Time:
00:03:37

Transcript
Important drug interactions between Victrelis (boceprevir) and ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitor drugs February 10, 2012

Listen to This Podcast
Run Time:
00:03:38

Transcript

Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs)

February 8, 2012

Listen to This Podcast
Run Time:
00:03:24

Transcript
New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab) January 20, 2012

Listen to This Podcast
Run Time:
00:04:54

Transcript
New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin) January 13, 2012

Listen to This Podcast
Run Time:
00:04:21

Transcript
Update - Preliminary findings from ongoing investigations of CardioGen-82 January 13, 2012

Listen to This Podcast
Run Time:
00:04:38

Transcript

Main Drug Safety Podcasts Page

Page Last Updated: 02/08/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English